The following are among the most popular spine and orthopedic device and implant stories this year:
When UCSF released its finding that Xenco Medical’s disposable, plastic surgical instrument outperformed a metal counterpart in a comparative strength study last October, the news spread quickly in the spinal device industry.
Healthcare themes in 2015 included consolidation, continuum of care integration and diversification; the year was no different for orthopedic device companies.
After the Australian government issued a warning about Stryker's LFIT Anatomic CoCr V40 femoral heads, physician/lawyer Shezad Malik believes a recall could be "imminent."
The Senate Finance Committee released a new report on physician-owned distributorships, focusing on spine surgeons.
Johnson & Johnson plans to cut around 3,000 jobs over the next two years as the company restructures its medical device business. Does this hint at disaster for the industry?
Smith & Nephew has completed the acquisition of Blue Belt Holdings, also known as Blue Belt Technologies.
Warsaw, Ind.-based Zimmer Biomet will acquire Austin, Texas-based LDR Holding for $1 billion.
DePuy Synthes, part of Johnson & Johnson Medical Devices companies, continues to push the boundaries of business with innovation that goes beyond device development.
Here are key notes on some of the leading companies in the spine device market space — where they are today and where they're headed.
Twenty-six key notes on orthopedic and spine device companies from early March 2016.
More articles on devices and implants:
FDA issues new cybersecurity rules for medical devices: 4 key takeaways
5 reasons why Medtronic is poised for growth in the next 5 years, despite a disappointing Q2
How 8 large orthopedic, spine device companies are doing financially